Disrupting cytokine signaling in pancreatic cancer: A phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease

Christina Wu, Soledad A. Fernandez, Tamara Criswell, Tarek A. Chidiac, Denis Guttridge, Miguel Villalona-Calero, Tanios S. Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Disrupting cytokine signaling in pancreatic cancer: A phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease'. Together they form a unique fingerprint.

Medicine & Life Sciences